Darling Ingredients heads into its April 30 Q1 earnings report with the Street in an unusually uniform bullish tilt — and the stock still trading at a discount to where analysts think it belongs.
The analyst story is the standout here. Every single target-price move in the past month has been an upgrade, and the direction has been steep. TD Cowen raised its target to $72 from $58 on April 28, while UBS lifted to $78 from $58 in early April — a 34% upward revision. JPMorgan, Baird, Jefferies, Scotiabank, and Stephens all followed suit, pushing the consensus mean target to roughly $72. The stock closed at $61.33 on April 28, leaving about 18% implied upside to consensus. Every recent action is a "maintain" on an existing positive rating — no upgrades from neutral needed, because there are no holdouts. That degree of pre-earnings target convergence is notable.
EPS momentum corroborates the bullish posture. Darling ranks in the 97th and 99th percentiles on 30-day and 90-day EPS momentum respectively, and the 94th percentile on forward EPS year-on-year growth — a near-perfect score card on the estimate-revision front. Valuation, by contrast, is the bear's clearest foothold: the P/E multiple has contracted roughly four points over the past 30 days to around 13.9x, and EV/EBITDA has drifted lower. Bulls read that as a buying opportunity against the revision momentum; bears read it as a ceiling forming.
Short positioning does nothing to complicate the story. Short interest is a modest 4.4% of the float — enough to register, but not extreme. Borrow costs are negligible at under 0.4%, and availability is very loose, well clear of the lending market's 52-week tightest level of 6.2%. There is no squeeze dynamic at play and no sign of aggressive short-side conviction building. Options lean mildly defensive — the put/call ratio is at 0.45, above its 20-day average of 0.38, but less than one standard deviation out. Investors are hedging lightly, not panicking.
Recent price action is steady rather than charged: the stock is up roughly 1.7% on the week and 3.5% on the month. Closest US peers ADM and BG tracked a similar pattern over the week, with ADM up around 3% and Bunge up around 1%, suggesting agricultural-sector tailwinds are broad rather than specific to DAR.
The earnings print will test whether the company's operational momentum — the basis for that wall of target hikes — is visible in the actual Q1 numbers, or whether the Street ran ahead of the fundamentals.
See the live data behind this article on ORTEX.
Open DAR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
